Posted by Michael Wonder on 30 Mar 2022
EMA starts rolling review of COVID-19 vaccine HIPRA (PHH-1V)
29 March 2022 - EMA’s CHMP has started a rolling review of COVID-19 Vaccine HIPRA (also known as PHH-1V).
This protein-based vaccine is being developed by HIPRA Human Health as a booster vaccine for adults who have already been fully vaccinated with a different COVID-19 vaccine.
